-transparent.png){kind=logo}
Bone marrow acid phosphatase was determined by radioimmunoassay and enzymatic analysis in 95 patients with benign prostatic hypertrophy, 50 patients with disseminated prostatic carcinoma and 36 patients with non-prostatic malignancy. The results indicate superior specificity of the radioimmunoassay. A brief review of the topic and the clinical implications are discussed.
Related Publications
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
January 1980,
The Prostate,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
January 1982,
Urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
June 1981,
JAMA,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
June 1981,
The Journal of urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
March 1983,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
October 1982,
Clinical chemistry,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
September 1975,
The Journal of urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
November 1980,
The Journal of urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
November 1991,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
W D Belville, and
H D Cox, and
D E Mahan, and
R E Stutzman, and
A W Bruce
March 1978,
The Journal of urology,
